MRAI

1.3000.78%
DF

Damien Francis Lamendola

President, CEO & Director

Mr. Damien Francis Lamendola is Director at Marpai, Inc. and Marpai Health, Inc. since April 1, 2021. He serves as Chief Executive Officer at Marpai, Inc since November 06, 2023 and serves as President since January 30, 2026. He served as Chief Executive Officer and President of WellDyneRx, Inc. Mr. Lamendola built his career directing operations across manufacturing, sales, business development and marketing. His career covers global operating experience with Monsanto Company, Dura Pharmaceuticals and Élan Pharmaceuticals holding executive positions throughout North America and Europe. He serves on the Board of Trustees for the economic development group called the Southeast Business Partnership. He is a successful Business Executive. Mr. Lamendola founded Continental Benefits in 2013 and was previously the Chief Executive Officer until 2019. Mr. Lamendola has served as President of HillCour Holding Corporation (f/k/a Welldyne Holding Corp.) since March 2002. Mr. Lamendola also continues to serves HillCour Holding Corporation as a Board Member since 2017, WellDyneRx, LLC as a Board Member since 2017 and HillCour Investment Fund, LLC as Manager since 2017. As President of HillCour Holding Corporation, Mr. Lamendola leads and oversees all strategic operations of multiple operating companies in the health care space. Mr. Lamendola has a B.S. in Chemical Engineering from McNeese State University. He also has an M.B.A. from Washington University.

Positions